Page last updated: 2024-11-05

trimethoprim and Centriacinar Emphysema

trimethoprim has been researched along with Centriacinar Emphysema in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brändli, O	1
Hasenhüttl, G	1

Other Studies

2 other studies available for trimethoprim and Centriacinar Emphysema

Article	Year
[Status asthmaticus following administration of drugs]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1988, Oct-18, Volume: 77, Issue:42 Topics: Aged; Anti-Infective Agents; Asthma; Drug Combinations; Humans; Lung Diseases, Obstructive; Male; Mi	1988
[Management of bronchial infections]. Wiener medizinische Wochenschrift (1946), 1973, Nov-03, Volume: 123, Issue:44 Topics: Asthma; Bronchial Diseases; Bronchiectasis; Bronchitis; Bronchopneumonia; Chronic Disease; Drug Comb	1973